Abstract
Purpose
Our objective was to compare the outcomes of rectal and non-rectal primary signet ring cell adenocarcinoma of the colorectum.
Methods
A retrospective survival analysis was performed using the Surveillance, Epidemiology, and End Results Program database between 2004 and 2009 on subjects who were diagnosed as having a primary signet ring cell carcinoma of the colorectum. Cox proportional hazard regression analysis controlled for confounders was used to assess overall survival comparing rectal and non-rectal cancers.
Results
Our population was composed of 1,484 patients: 200 affected by rectal cancer and 1,284 by non-rectal cancer. Unadjusted survival curves resulted to be almost superimposable (P = 0.916). After controlling for age, gender, race, tumor stage, grade, and size, tumor location demonstrated a statistically significant impact on overall survival (P = 0.032; 95 % confidence interval 0.640–0.980; hazard ratio 0.792).
Conclusion
On the basis of analysis of information from the SEER database, the signet ring cell carcinoma of the rectum was associated to a worse prognosis as compared to non-rectal cancer.
Similar content being viewed by others
References
Bittorf B, Merkel S, Matzel KE, Wein A, Dimmler A, Hohenberger W. Primary signet-ring cell carcinoma of the colorectum. Langenbecks Arch Surg. 2004;389(3):178–83.
Chen JS, Hsieh PS, Hung SY, Tang R, et al. Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis. 2004;19(2):102–7.
Connelly JH, Robey-Cafferty SS, Naggar AK, Cleary KR. Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med. 1991;115(2):134–6.
Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright Jr JB, Ray JE. Mucinous carcinoma—just another colon cancer? Dis Colon Rectum. 1993;36(1):49–54.
Kang H, O’Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;115(2):1161–8.
Messerini L, Palomba A, Zampi G. Primary signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 1995;38(11):1189–92.
Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM. Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum. 1999;42(9):1176–80.
Fardeli R, Campora E, Lapertosa E, Gentile G, Zoli R, Prior S, et al. Primary mucinous adenocarcinoma and signet ring cell carcinoma of colon and rectum. Oncology. 1994;51(1):1214–21.
Psathakis D, Schiedeck TH, Krug F, Oevermann E, et al. Ordinary colorectal adenocarcinoma vs primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade and stage. Dis Colon Rectum. 1999;42(12):1618–25.
Surveillance, Epidemiology, and End Results (SEER) Program (2002) Public use data (1973–1999). Cancer Statistics Branch, Surveillance Research Program, DCCPS. [Online] http://www.seer.cancer.gov.
The SEER Program coding and staging manual 2004. [Online] http://seer.cancer.gov/archive/manuals/2004Revision1/SPM_2004_maindoc.r1.pdf.
Appendix C: site specific coding modules. SEER Program coding and staging manual 2013. [Online] February 2013. http://seer.cancer.gov/manuals/2013/appendixc.html.
Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum. 2008;51:50–5.
Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006;19(1):59–68.
Robey-Cafferty SS, Naggar AK, Cleary KR, Connelly JH. Exophytic signet-ring cell carcinoma of the colorectum. Arch Pathol Lab Med. 1992;115(2):134–6.
Aste H, Baracchini P, Conio M, Fulcheri E, et al. Primary signet-ring carcinoma of the large bowel. Report of nine cases. Cancer. 1985;56(11):2723–6.
Song W, Wu SJ, He YL, Cai SR, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009;122(13):1486–91.
Grillo-Ruggieri F, Mantello G, Berardi R, Cardinali M, et al. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum. 2007;50(10):1594–603.
Box B, Lindsey I, Wheeler JM, Warren BF, et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum. 2005;122(13):1486–91.
Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37(4):1981–00.
Hyngstrom JR, Hu C-Y, Xing Y, You YN, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814–21.
Min BS, Kim NK, Ko YT, Baek SH, et al. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study. Hepatogastroenterology. 2009;56(93):984–8.
Shin US, Yu CS, Kim JH, et al. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol. 2011;18(8):2232–9.
Conflict of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ciarrocchi, A. Rectal Versus Non-rectal Primary Signet Ring Cell Carcinoma of the Colorectum: a Retrospective Survival Analysis Controlled for Confounders. J Gastrointest Canc 45, 312–318 (2014). https://doi.org/10.1007/s12029-014-9604-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-014-9604-0